Larvol Veri

BIOMARKER:

SNX2-ABL1 fusion

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

SNX2-ABL1 fusion SNX2-ABL1 fusion	Childhood B Acute Lymphoblastic Leukemia Childhood B Acute Lymphoblastic Leukemia	dasatinib Resistant: C4 – Case Studies dasatinib Resistant : C4
SNX2-ABL1 fusion SNX2-ABL1 fusion	B Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia	imatinib Sensitive: C4 – Case Studies imatinib Sensitive : C4
SNX2-ABL1 fusion SNX2-ABL1 fusion	Acute Lymphocytic Leukemia ALL	imatinib Resistant: D – Preclinical imatinib Resistant : D
SNX2-ABL1 fusion SNX2-ABL1 fusion	Acute Lymphocytic Leukemia ALL	dasatinib Resistant: D – Preclinical dasatinib Resistant : D